» Articles » PMID: 28710462

Plasticity in the Oxidative Folding Pathway of the High Affinity Nerita Versicolor Carboxypeptidase Inhibitor (NvCI)

Overview
Journal Sci Rep
Specialty Science
Date 2017 Jul 16
PMID 28710462
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Nerita Versicolor carboxypeptidase inhibitor (NvCI) is the strongest inhibitor reported so far for the M14A subfamily of carboxypeptidases. It comprises 53 residues and a protein fold composed of a two-stranded antiparallel β sheet connected by three loops and stabilized by three disulfide bridges. Here we report the oxidative folding and reductive unfolding pathways of NvCI. Much debate has gone on whether protein conformational folding guides disulfide bond formation or instead they are disulfide bonds that favour the arrangement of local or global structural elements. We show here that for NvCI both possibilities apply. Under physiological conditions, this protein folds trough a funnelled pathway involving a network of kinetically connected native-like intermediates, all sharing the disulfide bond connecting the two β-strands. In contrast, under denaturing conditions, the folding of NvCI is under thermodynamic control and follows a "trial and error" mechanism, in which an initial quasi-stochastic population of intermediates rearrange their disulfide bonds to attain the stable native topology. Despite their striking mechanistic differences, the efficiency of both folding routes is similar. The present study illustrates thus a surprising plasticity in the folding of this extremely stable small disulfide-rich inhibitor and provides the basis for its redesign for biomedical applications.

Citing Articles

Drug delivery targets and strategies to address mast cell diseases.

Rische C, Thames A, Krier-Burris R, OSullivan J, Bochner B, Scott E Expert Opin Drug Deliv. 2023; 20(2):205-222.

PMID: 36629456 PMC: 9928520. DOI: 10.1080/17425247.2023.2166926.


Total synthesis of μ-conotoxin lt5d.

Naraga A, Belleza O, Villaraza A RSC Adv. 2022; 8(64):36579-36583.

PMID: 35558937 PMC: 9088864. DOI: 10.1039/c8ra03706j.


Revisiting the Formation of a Native Disulfide Bond: Consequences for Protein Regeneration and Beyond.

Narayan M Molecules. 2020; 25(22).

PMID: 33207635 PMC: 7697891. DOI: 10.3390/molecules25225337.


A Chemical Biology Approach to Probing the Folding Pathways of the Inhibitory Cystine Knot (ICK) Peptide ProTx-II.

McCarthy S, Robinson J, Thalassinos K, Tabor A Front Chem. 2020; 8:228.

PMID: 32309273 PMC: 7145985. DOI: 10.3389/fchem.2020.00228.

References
1.
Scalley M, Baker D . Protein folding kinetics exhibit an Arrhenius temperature dependence when corrected for the temperature dependence of protein stability. Proc Natl Acad Sci U S A. 1997; 94(20):10636-40. PMC: 23430. DOI: 10.1073/pnas.94.20.10636. View

2.
Reverter D, Vendrell J, Canals F, Horstmann J, Aviles F, Fritz H . A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis. Isolation, sequence analysis, cDNA cloning, recombinant expression, and characterization. J Biol Chem. 1998; 273(49):32927-33. DOI: 10.1074/jbc.273.49.32927. View

3.
Chang J, Ballatore A . The structure of denatured bovine pancreatic trypsin inhibitor (BPTI). FEBS Lett. 2000; 473(2):183-7. DOI: 10.1016/s0014-5793(00)01515-5. View

4.
Kim P, Baldwin R . Intermediates in the folding reactions of small proteins. Annu Rev Biochem. 1990; 59:631-60. DOI: 10.1146/annurev.bi.59.070190.003215. View

5.
Arolas J, Ventura S . Protease inhibitors as models for the study of oxidative folding. Antioxid Redox Signal. 2010; 14(1):97-112. DOI: 10.1089/ars.2010.3456. View